Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
Katie L. Flanagan, Emma Best, Nigel Crawford, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants
Vasileios Papanikolaou, Aristeidis Chrysovergis, Vasileios Ragos, et al.
Gene (2022) Vol. 814, pp. 146134-146134
Open Access | Times Cited: 137
SARS‐CoV‐2 variants and vulnerability at the global level
Vivek P. Chavda, Aayushi Patel, Darsh D. Vaghasiya
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2986-3005
Open Access | Times Cited: 108
Impact of sewer overflow on public health: A comprehensive scientometric analysis and systematic review
Adebayo Olatunbosun Sojobi, Tarek Zayed
Environmental Research (2021) Vol. 203, pp. 111609-111609
Open Access | Times Cited: 95
Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis
Joanne S. K. Teh, Julien Coussement, Zoe C. F. Neoh, et al.
Blood Advances (2021) Vol. 6, Iss. 7, pp. 2014-2034
Open Access | Times Cited: 70
Potential antiviral activity of isorhamnetin against SARS‐CoV‐2 spike pseudotyped virus in vitro
Yingzhuan Zhan, Wenjing Ta, Wenjuan Tang, et al.
Drug Development Research (2021) Vol. 82, Iss. 8, pp. 1124-1130
Open Access | Times Cited: 66
One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages
Fernando Gónzález‐Candelas, Marie-Anne Shaw, Tung Gia Phan, et al.
Infection Genetics and Evolution (2021) Vol. 92, pp. 104869-104869
Open Access | Times Cited: 64
Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review
Swarnali Das, Suvrendu Sankar Kar, Sovan Samanta, et al.
Immunologic Research (2022) Vol. 70, Iss. 3, pp. 289-315
Open Access | Times Cited: 64
Perspectives on RNA Vaccine Candidates for COVID-19
Pobitra Borah, Pran Kishore Deb, Nizar A. Al‐Shar’i, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 55
Efficacy and Safety of BCG Revaccination With M. bovis BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial
Laura Raniere Borges dos Anjos, Adeliane Castro da Costa, Amanda da Rocha Oliveira Cardoso, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Emergence of SARS-CoV-2 Variants in the World: How Could This Happen?
Alfredo Parra-Lucares, Paula Segura, Verónica Rojas, et al.
Life (2022) Vol. 12, Iss. 2, pp. 194-194
Open Access | Times Cited: 42
Flavonoids derived from medicinal plants as a COVID‐19 treatment
Mentor Sopjani, Francesca Falco, Federica Impellitteri, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1589-1609
Open Access | Times Cited: 8
Active Surveillance of Adverse Events in Healthcare Workers Recipients After Vaccination with COVID-19 BNT162b2 Vaccine (Pfizer-BioNTech, Comirnaty): A Cross-Sectional Study
Giancarlo Ripabelli, Manuela Tamburro, Nicandro Buccieri, et al.
Journal of Community Health (2021) Vol. 47, Iss. 2, pp. 211-225
Open Access | Times Cited: 49
SARS-CoV-2 Vaccines: Where Are We Now?
Katie L. Flanagan, C. Raina MacIntyre, Peter McIntyre, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 10, pp. 3535-3543
Open Access | Times Cited: 43
Vaccines platforms and COVID-19: what you need to know
Isabel Acosta-Coley, Leonor Cervantes-Ceballos, Lesly Patricia Tejeda Benítez, et al.
Tropical Diseases Travel Medicine and Vaccines (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 33
COVID-19: vaccines, efficacy and effects on variants
Igor Rudan, Davies Adeloye, Aziz Sheikh
Current Opinion in Pulmonary Medicine (2022) Vol. 28, Iss. 3, pp. 180-191
Open Access | Times Cited: 31
Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2
Jordana Muñoz‐Basagoiti, Fábio L. Monteiro, Lauren R. H. Krumpe, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 10
Open Access | Times Cited: 15
COVID‐19 vaccination: are more jabs needed or are we now immune?
Michelle Giles, Katie L. Flanagan
Internal Medicine Journal (2024) Vol. 54, Iss. 3, pp. 368-373
Open Access | Times Cited: 5
SARS-CoV-2 spike protein in infectivity
Alaa Muayad Altaie, Rania Hamdy, Mohamed I. Husseiny, et al.
Elsevier eBooks (2025), pp. 21-56
Closed Access
Inactivated COVID-19 vaccines to make a global impact
Patrick L. Iversen, Sina Bavari
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 6, pp. 746-748
Open Access | Times Cited: 37
Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2
Kenneth S. Plante, Varun Dwivedi, Jessica A. Plante, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111457-111457
Open Access | Times Cited: 35
What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021
Jin‐Hong Yoo
Journal of Korean Medical Science (2021) Vol. 36, Iss. 6
Open Access | Times Cited: 33
COVID-19 and Dentistry in 72 Questions: An Overview of the Literature
Stéphane Derruau, Jérôme Bouchet, Ali Nassif, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 779-779
Open Access | Times Cited: 30
Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients
Behnam Hashemi, Akram Firouzi‐Amandi, Halimeh Amirazad, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 67, pp. 102967-102967
Open Access | Times Cited: 27
Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2
Espiridión Ramos-Martı́nez, Ramcés Falfán‐Valencia, Gloria Pérez‐Rubio, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3179-3179
Open Access | Times Cited: 27
Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro
Binli Mao, Vu Thuy Khanh Le‐Trilling, Kai Wang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 483-497
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top